Diagnostics

Australian Healthcare Buyers Issue a Warning to Technology Vendors: Innovation Alone Will Not Win 2027 Contracts

Black Book surveys identify three new procurement gates reshaping Australia's digital-health market: AI accountability, operational interoperability and implementation credibility SYDNEY,...

Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs

BERKELEY, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies,...

Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies

Multi-year research collaboration will focus initially on AML and MDS while advancing Electronic Genome Mapping for broader hematologic research applicationsPROVIDENCE,...

Alveo Technologies Partners with University of Texas Medical Branch (UTMB) to Develop Point-of-Care Diagnostics for Lassa Fever in West Africa

Point-of-care diagnostic will deploy across clinical sites in Nigeria and Sierra LeoneALAMEDA, Calif., July 29, 2026 /PRNewswire/ -- Alveo Technologies,...

Practice at the Speed of Innovation™ A New Podcast and Video Series Exploring the AI Enabled Future of Community Oncology Presented by Oncologic.ai

Recorded at the 2026 COA and ASCO conferences, the series brings together many of the nation's leading physicians, practice executives,...

NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion Animals

Company targets a growing $1.2B+ North American pet oncology market leveraging proprietary exosome-based diagnostic technologies. ORLANDO, FL / ACCESS Newswire...

Vivid Dx Raises $15M to Help Hospitals Confront One of Modern Medicine’s Most Urgent Threats: Drug-Resistant Infections

As antimicrobial resistance accelerates, when every hour can matter, faster diagnostics can help clinicians get patients on the right antibiotics...

Vivid Dx Raises $15M to Help Hospitals Confront One of Modern Medicine’s Most Urgent Threats: Drug-Resistant Infections

As antimicrobial resistance accelerates, when every hour can matter, faster diagnostics can help clinicians get patients on the right antibiotics...

George E. Norcross III to Donate $100 Million to Cooper University Health Care/MD Anderson Cancer Center at Cooper in Honor of His Parents, George E. Norcross Jr. and Anne Carol Conner Norcross

error: Content is protected !!